In fall 2019, many of the enigmatic pneumonia patients of unknown etiology have been recorded in Wuhan, Hubei, a province of China which has received worldwide attention (Zhu et al. We also addressed the possibilities of practical applications of nanoparticles to give the status of COVID-19 antiviral systems.Ī rising number of cases of novel coronaviruses recognized as severe acute respiratory coronavirus-2 syndrome known as SARS-CoV-2 have been causing serious human infections with viral pneumonia (COVID-19) since December 2019 (Huang et al. The use of nanomaterials in treatment against SARS-CoV-2 and their use as carriers for the transport of the most frequently used antiviral therapeutics are discussed systematically here. In this review, we presented an up-to-date drug design strategy against SARS-CoV-2, including the development of novel drugs and repurposed product potentials were useful, and successful drugs discovery is a constant requirement. Nanomedicine has outstanding potential to solve several specific health issues, like viruses, which are regarded a significant medical issue. No successful treatment has yet been shown although enormous international commitment to combat this pandemic and the start of different clinical trials.
Very recently, new variant of SARS-CoV-2 is identified in many countries which make the situation very critical. Researchers have been working to find a new drug to combat the virus since the outbreak started in late 2019, but there are currently no successful drugs to control the SARS-CoV-2, which makes the situation riskier. This virus accounts for the ongoing outbreak and forces an urgent need to improve antiviral therapeutics and targeted diagnosing tools. SARS-CoV-2 (COVID-19) spreads and develops quickly worldwide as a new global crisis which has left deep socio-economic damage and massive human mortality.
0 kommentar(er)
